Ezetimibe & Simvastatin USP Tablets
Ezetimibe & Simvastatin Tablets USP combine cholesterol absorption inhibition with statin therapy for powerful lipid-lowering results. Manufactured to USP standards for consistent potency and global B2B supply.
Brand Name: EZETIMIBE-S
Generic Name: Ezetimibe & Simvastatin USP Tablets
Available Strengths:
10mg+10mg/10mg+20mg/10mg+40mg/10mg+80mg
Ezetimibe & Simvastatin Tablets USP offer a dual-mechanism solution for managing hypercholesterolemia by reducing intestinal cholesterol absorption and inhibiting hepatic cholesterol synthesis. This combination effectively lowers LDL, total cholesterol, and triglycerides while improving HDL levels. Produced under strict GMP and USP guidelines, these tablets ensure reliable purity, stability, and therapeutic performance. Widely preferred for chronic lipid management, they are ideal for hospitals, tenders, pharmacies, private-label brands, and international distributors seeking a trusted and effective dyslipidemia treatment for large-scale global procurement and export markets.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com